InvestorsHub Logo
Replies to #120 on Evolus (EOLS)

enthalpy

02/07/20 10:11 AM

#121 RE: DewDiligence #120

there must be something wrong with company as the shorts are betting hugely against it. Revance doesn't even have FDA Approval yet. I have to come to grips this just a $10 stock nothing more.